VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | The management of advanced phase MPNs

Abdulraheem Yacoub, MD, The University of Kansas, Westwood, KS, shares some insights into the management of accelerated phase myeloproliferative neoplasms (MPN-AP) and the need to design and conduct more clinical trials for patients with advanced disease. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Disclosures

Advisory role: Incyte, CTI Pharma , Pharmaessentia, Pfizer, Novartis, ACCELERON PHARMA, Agios ABBVIE, Apellis, Gilead, Notable Labs. Research Support: CTI Pharma, Stemline Therapeutics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter